Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

Por Grill, Jacques, Geoerger, Birgit, Gesner, Lyle, Perek, Danuta, Leblond, Pierre, Cañete, Adela, Aerts, Isabelle, Madero, Luis, de Toledo Codina, Josep Sanchez, Verlooy, Joris, Estlin, Edward, Cisar, Laura, Breazna, Aurora, Dorman, Andrew, Bailey, Simon, Nicolin, Gary, Grundy, Richard G., Hargrave, Darren
Publicado em 2013